ATC Group: A07EC02 Mesalazine

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Intestinal antiinflammatory agents
4
Aminosalicylic acid and similar agents
5
A07EC02
Mesalazine

Active ingredients

Active Ingredient
Description

Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.

Medicines in this ATC group

Drug
Countries

Australia Canada Cyprus Germany Hong Kong ...

Brazil

Austria

Tunisia

Austria Germany Spain

France

Ireland

Brazil Lithuania

Australia

Tunisia

Australia Austria Canada Cyprus Germany ...

Canada

United Kingdom

Australia Austria Brazil Canada Cyprus ...

France United States

Australia Austria Canada Cyprus Germany ...

Austria Lithuania Netherlands

United Kingdom

Related product monographs

Title
Type
Country
Summary of product characteristics (SPC)
UK
Summary of product characteristics (SPC)
UK
Structured product labeling (SPL)
US